{"id":"W4413815245","doi":"10.1016/j.jaad.2025.08.070","title":"Response to: “Response to Bissonnette et al. Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy control–matched, phase 4 clinical study (BALISTAD)”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Filaggrin; Atopic dermatitis; Dermatology; Genotype","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001444133,0.0006753326,0.001011376,0.0005244096,0.002363778,0.001877888,0.001084857,0.0218725,0.009893826],"category_scores_gemma":[0.007785257,0.0003603902,0.0009249978,0.0005044778,0.0009947427,0.001455466,0.0006007886,0.01254413,0.007461866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003019432,"about_ca_system_score_gemma":0.002270208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005434809,"about_ca_topic_score_gemma":0.008958942,"domain_scores_codex":[0.9986971,0.00033082,0.0001579879,0.0002193496,0.0003185096,0.0002762884],"domain_scores_gemma":[0.997826,0.0008273427,0.0002053417,0.00006649914,0.0005652496,0.0005095708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003541735,0.0001170755,0.001662507,0.00006250908,0.00003456684,0.003893647,0.00008565516,0.00008430782,0.0003256818,0.0006131937,0.9857253,0.007041365],"study_design_scores_gemma":[0.00147458,0.0006754308,0.01012247,0.0005074098,0.0001538906,0.009894582,0.0007892152,0.001755242,0.0009975092,0.004985121,0.9684956,0.0001488433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0027625,0.0007555056,0.0001156033,0.9770749,0.01239814,0.00007122491,0.0004569273,0.0001085996,0.00625669],"genre_scores_gemma":[0.01144401,0.0005682525,0.0002192414,0.9618626,0.01536987,0.00007470659,0.0002524478,0.00003889182,0.01016998],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0218725,"threshold_uncertainty_score":0.03309816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02626856573244947,"score_gpt":0.3829688553061605,"score_spread":0.3567002895737111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}